Therapy News and Research

RSS

COVID-19 presents caregivers with unique challenges not seen in other patients

Roughly 21% of hospitalized COVID-19 patients at the height of the pandemic required an intensive care stay and the bulk were cared for by family upon discharge.

31 Oct 2022

Increasing Awareness Surrounding Ataxia

In this interview, we speak to Dr. Lauren Moore from the National Ataxia Foundation about the condition and the importance of raising awareness for ataxia.

31 Oct 2022

New method to improve nanoparticle coating may enhance tumor targeting

A new technique to improve the coating of nanoparticles used in cancer therapy may enhance tumour targeting, a new study carried out in collaboration between the University of Eastern Finland and Anhui Medical University in China concludes.

31 Oct 2022

What are the implications of microbial ecosystems for female reproductive health?

Researchers reviewed the current understanding of the composition and temporal dynamics of microbial niches in the female reproductive tract.

31 Oct 2022

Does maternal obesity impact fetal brain development?

In a new study, researchers assessed the impact of maternal obesity on brain development in the fetus.

31 Oct 2022

Investigators study symptom trajectories in nondialysis-dependent CKD patients

When individuals with varying degrees of chronic kidney disease who were not on dialysis answered annual questionnaires about their symptoms, researchers found that one-third could be categorized as having a "Worse symptom score and worsening trajectory" of symptoms.

30 Oct 2022

World Stroke Day 2022: Why saving #Precioustime is imperative

For World Stroke Day 2022, News-Medical speaks to Dr. Patrick Brouwer, Head of Worldwide Medical Affairs at CERENOVUS, about why saving #Precioustime is critical when it comes to recognizing and seeking medical treatment for stroke.

29 Oct 2022

Standard cutoff point for low testosterone levels may not be accurate for young men

The standard cutoff point for low testosterone levels may not be accurate for men in their mid-forties and younger, reports a study in The Journal of Urology, an Official Journal of the American Urological Association (AUA).

28 Oct 2022

Cleveland Clinic awarded $12 million NIH grant to define how cytokines regulate inflammation

Cleveland Clinic's Lerner Research Institute was awarded a five-year $12 million grant by the National Cancer Institute, part of the National Institutes of Health, to define how cytokines - proteins produced during immune response - regulate inflammation and interact with cells and molecules surrounding tumors.

28 Oct 2022

Researchers propose origin-of-life molecule as therapeutic target for tailored cancer therapies

RNA, the molecule that gave rise to life, has been shown to be essential for repairing human genetic material and preventing mutations that might lead to developing cancer.

28 Oct 2022

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

A Ludwig Cancer Research study has developed a novel nanotechnology that triggers potent therapeutic anti-tumor immune responses and demonstrated its efficacy in mouse models of multiple cancers.

28 Oct 2022

Rehabilitation plus stem cell grafting after spinal cord injury can augment functional outcomes

In recent years, researchers have made measurable progress, using animal models, to promote tissue regeneration in spinal cord injuries (SCI) through implanted neural stem cells or grafts. Other efforts have shown that intensive physical rehabilitation can improve function after SCI by promoting greater or new roles for undamaged or spared cells and neural circuits.

28 Oct 2022

Specific stem cell protein found to be involved in the recurrence of medulloblastoma

The malignant brain tumor type medulloblastoma can become resistant to therapy which can cause relapse. Researchers at Uppsala University have discovered a certain protein that makes tumor cells resting and insensitive to radiation treatment.

28 Oct 2022

Brain Canada Foundation funds future leaders in Canadian brain research

Twenty early-career researchers from across Canada will receive $100,000 each in funding for innovative projects to better understand the brain, through one of Brain Canada's flagship programs Future Leaders in Canadian Brain Research.

28 Oct 2022

CU Anschutz study details the mechanisms behind the link between shingles and strokes

Scientists investigating why people who have had shingles are at a higher risk of stroke, now believe the answer lies within lipid vesicles called exosomes that shuttle proteins and genetic information between cells, according to new research from the University of Colorado Anschutz Medical Campus.

28 Oct 2022

Overall cancer death rates continue to decline in the United States, says Annual Report to the Nation

Overall cancer death rates continued to decline among men, women, children, and adolescents and young adults in every major racial and ethnic group in the United States from 2015 to 2019, according to the latest Annual Report to the Nation on the Status of Cancer. From 2014 to 2018, overall cancer incidence, or new cases of cancer, remained stable for men and children but increased for women and adolescents and young adults.

28 Oct 2022

Proof-of-principle study: Novel tool advances potential way to deliver gene therapy

Johns Hopkins Medicine researchers say they have successfully used a cell's natural process for making proteins to "slide" genetic instructions into a cell and produce critical proteins missing from those cells.

28 Oct 2022

Scientists computationally restore the potency of an antibody against SARS-CoV-2 Omicron subvariants

A team of researchers from the United States computationally modified the COV2-2130 monoclonal antibody to restore its neutralizing ability against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants, while retaining efficacy against the Delta and wild-type strains.

27 Oct 2022

Researchers use CRISPR-edited T cells to treat seriously ill children with resistant leukaemia

Researchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have used CRISPR/Cas9 technology to engineer donor T cells to try to treat seriously ill children with resistant leukaemia, who had otherwise exhausted all available therapies.

27 Oct 2022

Newly developed chemical compounds show promise as potential anticancer therapy

A University of Kentucky Markey Cancer Center researcher's team developed new chemical compounds that show promise as a potential anticancer therapy to treat aggressive tumors.

27 Oct 2022

Therapy News and Research

COVID-19 presents caregivers with unique challenges not seen in other patients

Increasing Awareness Surrounding Ataxia

New method to improve nanoparticle coating may enhance tumor targeting

What are the implications of microbial ecosystems for female reproductive health?

Does maternal obesity impact fetal brain development?

Investigators study symptom trajectories in nondialysis-dependent CKD patients

World Stroke Day 2022: Why saving #Precioustime is imperative

Standard cutoff point for low testosterone levels may not be accurate for young men

Cleveland Clinic awarded $12 million NIH grant to define how cytokines regulate inflammation

Researchers propose origin-of-life molecule as therapeutic target for tailored cancer therapies

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

Rehabilitation plus stem cell grafting after spinal cord injury can augment functional outcomes

Specific stem cell protein found to be involved in the recurrence of medulloblastoma

Brain Canada Foundation funds future leaders in Canadian brain research

CU Anschutz study details the mechanisms behind the link between shingles and strokes

Overall cancer death rates continue to decline in the United States, says Annual Report to the Nation

Proof-of-principle study: Novel tool advances potential way to deliver gene therapy

Scientists computationally restore the potency of an antibody against SARS-CoV-2 Omicron subvariants

Researchers use CRISPR-edited T cells to treat seriously ill children with resistant leukaemia

Newly developed chemical compounds show promise as potential anticancer therapy

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News